Fundraising Fox
Digestiva/Amplifye
Davis, US · Delaware corporation · 5 known investors
Find your way into Digestiva/Amplifye
Sign up to see every warm intro you have to Digestiva/Amplifye
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Digestiva/Amplifye team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Digestiva develops proprietary protease enzymes that break down proteins to produce more bioaccessible and smaller peptides, increase free amino acid availability, and improve protein yield from co-products and waste streams. Its technology targets applications in health, nutrition, and food processing.
Founders & leadership
JH
Julie HirschChief Operations Officer2023–2025Julie Hirsch is an executive officer at Digestiva, bringing over 20 years of commercial experience in food, OTC pharmaceuticals, cosmetics, and food biotech, with expertise in ingredients, formulations, processing, and regulatory affairs.
JM
John MeloExecutive
JS
Justin SiegelNamed on SEC filing
Board
HS
IA
Irina AdlerBoard director
GP
George PowlickBoard director
JL
Jorge LealBoard director
Investors · 5
Also in the syndicate · 4
AstanorMagdalenaleadMarch FundUC Investments
Reported raises · per SEC filings
Form D private placements$18.4M disclosed across 1 round · 2024
▶$18.4MraisedJul 2024 · 5 investors · Other Health CareRule 506(b)
▶$18.4MraisedJul 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Irina AdlerDirector
- George PowlickDirector
- Harold SchmitzDirector
- Justin SiegelExecutive Officer
- Julie HirschExecutive Officer
- John MeloExecutive Officer, Director
- Jorge LealDirector
- Offering amount
- $19.4M
- Amount sold
- $18.4M
- Minimum investment
- $1
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Digestiva/Amplifye do?
- Digestiva develops proprietary protease enzymes that break down proteins to produce more bioaccessible and smaller peptides, increase free amino acid availability, and improve protein yield from co-products and waste streams. Its technology targets applications in health, nutrition, and food processing.
- Who are Digestiva/Amplifye's investors?
- Digestiva/Amplifye's investors include The March Group.
- How much funding has Digestiva/Amplifye raised?
- Digestiva/Amplifye has disclosed $18.4M raised across 1 round.
- Where is Digestiva/Amplifye headquartered?
- Digestiva/Amplifye is headquartered in Davis, US.